Pathways through which GALNT2 impairs lipid metabolism and insulin resistance have been partly identified, while those connecting GALNT2 to hyperglycemia/type 2 diabetes and obesity are only scarcely understood. Here, GALNT2 is linked to obesity due to melanocortin 4 receptor deficiency.